AstraZeneca scores speedy FDA review for Farxiga based on ‘innovative’ heart attack trial design

AstraZeneca scores speedy FDA review for Farxiga based on ‘innovative’ heart attack trial design
kblankenship
Fri, 07/17/2020 – 08:55